Abstract
A sensitive and robust LC–MS method for quantifying memantine (MEM) concentrations in mouse brain homogenate and perfusate was developed and validated. The developed LC–MS method exhibited good linearity between response and MEM concentrations in both perfusate and brain homogenate (r2=0.98–0.99) with mean accuracy and precision values of 105.6% and 7.7% (for perfusate) and 99.0% and 9.5% (for brain homogenate). This assay was then applied to determine the impact of reported blood–brain barrier (BBB) alterations in Alzheimer's disease (AD) on the CNS exposure of the anti-AD drug, MEM. The brain uptake of MEM was measured in 12–13 and 17–19 month old wild-type (WT) and triple transgenic (3×Tg) AD mice using the developed LC–MS assay and a transcardiac perfusion technique. The transcardiac perfusion technique was validated in our laboratory with marker compounds (each representing different mechanisms of transport across the BBB) to ascertain that the physical and functional properties of the BBB were maintained using this technique. While the brain uptake of MEM was not significantly different between WT and 3×Tg mice at 12–13 months, MEM brain uptake was significantly (p<0.05) decreased by 43% in 17–19 month old 3×Tg mice relative to WT mice. Using this novel LC–MS technique, the CNS exposure of a therapeutically-relevant drug, MEM, has been shown to be decreased in AD, implying a need to assess the impact of this disorder on the brain uptake of other therapeutically-relevant compounds.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.